Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To evaluate the effect of recombinant erythropoietin on hospitalised COVID-19 patients. TRIAL DESIGN: Concealed, randomized, single-blinded, phase 2 controlled clinical trial with two arm parallel-group design of 20 patients allocated with 1:1 ratio and using the placebo in the control g...

Descripción completa

Detalles Bibliográficos
Autores principales: Samimagham, Hamid Reza, Azad, Mehdi Hassani, Hooshyar, Dariush, Haddad, Maryam, Arabi, Mohsen, KazemiJahromi, Mitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258474/
https://www.ncbi.nlm.nih.gov/pubmed/34229729
http://dx.doi.org/10.1186/s13063-021-05363-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258474/
https://www.ncbi.nlm.nih.gov/pubmed/34229729
http://dx.doi.org/10.1186/s13063-021-05363-w

Ejemplares similares